Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 2, 2015, Pages E147-E155

  Arlehamn, Cecilia S Lindestam ^a   Paul, Sinu ^a   Mele, Federico ^b   Huang, Charlie ^a   Greenbaum, Jason A ^a   Vita, Randi ^a   Sidney, John ^a   Peters, Bjoern ^a   Sallusto, Federica ^b   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

Epitope conservation; NTM; T cell epitope; T cell subset; Tuberculosis

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; EPITOPE; BACTERIAL ANTIGEN; BCG VACCINE; CCR6 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN;

ADAPTATION; ADULT; ANTIGEN RECOGNITION; ARTICLE; ATYPICAL MYCOBACTERIUM; CROSS REACTION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MEMORY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; AMINO ACID SEQUENCE; BACTERIAL GENOME; CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LATENT TUBERCULOSIS; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SPECIES DIFFERENCE;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CONSERVED SEQUENCE; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; GENOME, BACTERIAL; GENOME-WIDE ASSOCIATION STUDY; HOST-PATHOGEN INTERACTIONS; HUMANS; LATENT TUBERCULOSIS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; RECEPTORS, CCR6; RECEPTORS, CXCR3; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS VACCINES;

EID: 84920941837     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1416537112     Document Type: Article

References (48)

1. Glassroth J (2008) Pulmonary disease due to nontuberculous mycobacteria. Chest 133(1):243-251.
2. Wolinsky E (1979) Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119(1):107-159.
3. Comas I, et al. (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42(6):498-503.
4. Baena A, Porcelli SA (2009) Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 74(3):189-204.
5. Black GF, et al. (2001) Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 184(3):322-329.
6. Black GF, et al. (2003) Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCGvaccinated Malawian young adults. Clin Diagn Lab Immunol 10(4):602-611.
7. Leyten EMS, et al. (2006) Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8(8): 2052-2060.
8. Lin MY, et al. (2007) Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun 75(7):3523-3530.
9. Alvarez-Uria G (2010) Lung disease caused by nontuberculous mycobacteria. Curr Opin Pulm Med 16(3):251-256.
10. De Groote MA, Pace NR, Fulton K, Falkinham JO, 3rd (2006) Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils. Appl Environ Microbiol 72(12):7602-7606.
11. September SM, Brözel VS, Venter SN (2004) Diversity of nontuberculoid Mycobacterium species in biofilms of urban and semiurban drinking water distribution systems. Appl Environ Microbiol 70(12):7571-7573.
12. Somoskovi A, Salfinger M (2014) Nontuberculous mycobacteria in respiratory infections: Advances in diagnosis and identification. Clin Lab Med 34(2):271-295.
13. Falkinham JO, 3rd (2009) Surrounded by mycobacteria: Nontuberculous mycobacteria in the human environment. J Appl Microbiol 107(2):356-367.
14. Ivanyi J (2014) Function and Potentials of M. tuberculosis Epitopes. Front Immunol 5:107.
15. Fine PE (1995) Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 346(8986):1339-1345.
16. Wilson ME, Fineberg HV, Colditz GA (1995) Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine. Clin Infect Dis 20(4):982-991.
17. Collins FM (1971) Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species. Infect Immun 4(6):688-696.
18. Orme IM, Collins FM (1984) Adoptive protection of the Mycobacterium tuberculosisinfected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 84(1):113-120.
19. Hope JC, Kwong LS, Sopp P, Collins RA, Howard CJ (2000) Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle. Scand J Immunol 52(3):285-291.
20. Howard CJ, Kwong LS, Villarreal-Ramos B, Sopp P, Hope JC (2002) Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG. Clin Exp Immunol 130(2):190-195.
21. Young SL, et al. (2007) Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect Immun 75(6):2833-2840.
22. Lindestam Arlehamn CS, et al. (2013) Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog 9(1):e1003130.
23. Geiger R, Duhen T, Lanzavecchia A, Sallusto F (2009) Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 206(7):1525-1534.
24. Ramakrishnan L (2012) Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 12(5):352-366.
25. Archila LD, et al. (2014) Grass-specific CD4(+) T-cells exhibit varying degrees of crossreactivity, implications for allergen-specific immunotherapy. Clin Exp Allergy 44(7): 986-998.
26. Chiu C, et al. (2014) Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog 10(3):e1004008.
27. Birnbaum ME, et al. (2014) Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157(5):1073-1087.
28. Harris DP, et al. (1991) Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae. J Immunol 147(8):2706-2712.
29. Harris DP, et al. (1995) Cross-recognition by T cells of an epitope shared by two unrelated mycobacterial antigens. Eur J Immunol 25(11):3173-3179.
30. Ishizuka J, et al. (2009) Quantitating T cell cross-reactivity for unrelated peptide antigens. J Immunol 183(7):4337-4345.
31. LinMY, et al. (2009) Cross-reactive immunity toMycobacterium tuberculosis DosR regulonencoded antigens in individuals infected with environmental, nontuberculous mycobacteria. Infect Immun 77(11):5071-5079.
32. Scriba TJ, et al. (2010) Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol 40(1):279-290.
33. von Reyn CF, et al. (2001) Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 5(12):1122-1128.
34. Demangel C, Garnier T, Rosenkrands I, Cole ST (2005) Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 73(4): 2190-2196.
35. Orme IM, Collins FM (1986) Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med 163(1):203-208.
36. Thom M, et al. (2008) Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Tuberculosis (Edinb) 88(4): 324-334.
37. Brandt L, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70(2):672-678.
38. Fine PE, Vynnycky E (1998) The effect of heterologous immunity upon the apparent efficacy of (e. g. BCG) vaccines. Vaccine 16(20):1923-1928.
39. Hernandez-Pando R, et al. (1997) Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 65(8):3317-3327.
40. McShane H, et al. (2004) Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10(11):1240-1244.
41. Tameris MD, et al.; MVA85A 020 Trial Study Team (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet 381(9871):1021-1028.
42. Acosta-Rodriguez EV, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8(6):639-646.
43. Arlehamn CL, et al. (2014) Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol 193(6):2931-2940.
44. Weir RE, et al. (2003) Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol 134(2):285-294.
45. Checkley AM, et al. (2011) Identification of antigens specific to non-tuberculous mycobacteria: The Mce family of proteins as a target of T cell immune responses. PLoS ONE 6(10):e26434.
46. McKinney DM, et al. (2013) A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population. Immunogenetics 65(5):357-370.
47. Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3(5):418-426.
48. Tamura K, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731-2739.